Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Aïda Amer/Axios

U.S. auto sales have bounced back in recent months despite the coronavirus pandemic, with some brands even seeing their sales increase over 2019's numbers at this point in the year.

Why it matters: Cars and trucks were seen as one of the sectors that would be hardest hit as Americans were called to stay home from work and entertainment destinations were shuttered.

Driving the news: U.S. factory orders rose 6.2% in June, more than expected and boosted by a surge in demand for motor vehicles, after gaining 7.7% in May, the Commerce Department reported Tuesday.

  • Orders for motor vehicles and parts jumped 86.2%, with overall transportation equipment orders up 20.2% after a 78.8% climb the prior month.

Sales of Volvo, Mazda and Hyundai have all risen from 2019's levels this year, with Volvo charting a 10.3% increase over July 2019, its best July in 14 years.

  • Mazda sales are up 3.4%.
  • Hyundai reported a year-on-year gain of 0.6% in U.S. sales for July.
  • Kia's reported overall sales were down, but just 1.7% lower than last year's July tally.
  • Toyota sales last month fell 19% year over year, but the company notched its best month since February, before the pandemic shuttered North American production and led to closed showrooms across the country, Reuters reported.

Of note: Detroit's three carmakers posted better-than-expected earnings for the second quarter, despite two-month factory shutdowns, Axios' Joann Muller noted Friday, with each of the companies outperforming Wall Street expectations.

Yes, but: Factory orders overall remain well below their February level, and June's reading was 10.1% below June 2019's level.

  • Autos are expected to see a year-over-year volume decline of 25%-30%, according to IHS Markit principal automotive analyst Stephanie Brinley.
  • Additionally, economists warn that the rebound in auto sales could be threatened by recent increases of COVID-19 in southern and western states.

Yes, but, but: Investors are betting that the uncertainty will push more consumers to buy online from vendors like CarMax, Carvana and Vroom, which have spent billions building online platforms, digital networks and inventory for just this moment.

  • Vroom's stock is up nearly 25% since it debuted on the Nasdaq in early June.
  • During that time Carvana's stock is up more than 45% (and up over 80% year to date and 155% over the past year).
  • CarMax's stock has gained a little under 5% since early June — it's the largest used car dealer in the U.S. but has a significant brick-and-mortar presence, making investors concerned about pandemic-related disruptions.

Go deeper

Updated Nov 9, 2020 - Economy & Business

Stock market rises after Pfizer coronavirus vaccine news

A face mask hanging on the fence of the New York Stock Exchange. Photo: Lev Radin/Pacific Press/LightRocket via Getty Images

The Dow closed up 2.9%, or 835 points, after Pfizer announced promising, though early, findings about the effectiveness of its coronavirus vaccine. The S&P 500 finished up 1.2%.

The state of play: The vaccine progress is fueling market optimism about a possible return to normal, as the coronavirus pandemic and social-distancing restrictions have held back the U.S. economy.

Dion Rabouin, author of Markets
Nov 10, 2020 - Economy & Business

The winners and losers in the market's vaccine rally

Reproduced from Charles Schwab; Chart: Axios Visuals

Risk assets had a very good day on Monday, but U.S. stock performance was mixed after news that a COVID-19 vaccine from Pfizer and BioNTech could be distributed to millions of people before the end of the month.

Why it matters: Beyond just stocks, Monday's market moves clearly reflected investor enthusiasm and a market pricing in a return to pre-pandemic life that will benefit risk at the expense of safety.

Updated 1 hour ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

  1. Health: Fall and winter COVID surge "unlikely" if people get vaccinated.
  2. Politics: School boards are the next political battleground.
  3. Vaccines: Pfizer begins application for full FDA vaccine approval — Moderna says its COVID booster shot shows promise against variants.
  4. Economy: U.S. adds just 266,000 jobs in April, far below expectations.
  5. World: Asia faces massive new COVID surgeIndia records its deadliest day of the pandemic.
  6. Variant tracker: Where different strains are spreading.